BONE TUMOR ABLATION DEVICES MARKET ANALYSIS

Bone Tumor Ablation Devices Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), by Indication (Osteosarcoma, Chondrosarcoma, Ewing’s Sarcoma, Metastatic Bone Cancer, and Others), by End user (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Dec 2020
Code : CMI4319
Pages :183
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Increasing Product Launches of Bone Tumor Ablation Devices are expected to boost growth of the Bone Tumor Ablation Devices market

Key players in the market are involved in developing novel bone tumor ablation devices and launching them in the market. The launch of such advanced systems in the market is expected to significantly drive the market growth and create conductive environment for bone tumor ablation devices market over the forecast period. For instance, Medtronic Plc. launched OsteoCool RF Ablation System to treat spine metastases in January 2016. It offers simultaneous, dual-probe capabilities for treating painful bone tumors. Moreover, in 2017, Medtronic plc, launched OsteoCool RF Ablation system in Canada for the indication of bone metastases. Furthermore, in 2015, DFINE, Inc. launched Long SpineSTAR ablation instrument for the palliative treatment of metastatic spine tumors. The SpineSTAR ablation instrument is the only steerable and navigational radiofrequency device in the market.

Bone Tumor Ablation Devices Market - Competitive Landscape

Key players operating in the global bone tumor ablation devices market include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.